{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:57:33Z","timestamp":1784264253732,"version":"3.55.0"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T00:00:00Z","timestamp":1169510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> Although immunotherapy has been reported as the only treatment able to revert the T\u2010helper type 2 (Th2) response, its administration has some disadvantages such as the requirement of multiple doses, possible side\u2010effects provoked by conventional adjuvants and the risk of suffering an anaphylactic shock. For these reasons, drug\u2010delivery systems appear to be a promising strategy due to its ability to (i) transport the allergens, (ii) protect them from degradation, (iii) decrease the number of administrations and (iv) act as immuno\u2010adjuvants.<\/jats:p><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> The aim of this work was to evaluate the properties of poly\u2010\u025b\u2010caprolactone (PCL) microparticles as adjuvants in immunotherapy using ovalbumin (OVA) as an allergen model. For this purpose, the protection capacity of these microparticles (OVA PCL) against OVA allergy was studied in a murine model.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> The humoral and cellular\u2010induced immune response generated by OVA encapsulated into PCL microparticles was studied by immunizing BALB\/c mice intradermically. Also, OVA\u2010sensitized mice were treated with OVA PCL and OVA adsorbed to aluminium hydroxide (OVA\u2010Alum). Fifteen days after therapy, animals were challenged with OVA and different signs of anaphylactic shock were evaluated.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> One single shot by an intradermal route with OVA PCL resulted in a Th2\u2010type immune response. In OVA\u2010sensitized mice, treatment with OVA PCL elicited high OVA\u2010specific IgG but low levels of IgE. Furthermore, OVA PCL mice group displayed lower levels of serum histamine and higher survival rate in comparison with the positive control group.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> The anaphylactic shock suffered by OVA PCL\u2010treated mice was weaker than the one induced in the OVA\u2010Alum group. Hence, the intradermal immunization with OVA PCL microparticles induced hyposensitization in OVA\u2010allergic mice.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2007.02654.x","type":"journal-article","created":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T11:18:44Z","timestamp":1169551124000},"page":"287-295","source":"Crossref","is-referenced-by-count":16,"title":["Intradermal immunization with ovalbumin\u2010loaded poly\u2010\u025b\u2010caprolactone microparticles conferred protection in ovalbumin\u2010sensitized allergic mice"],"prefix":"10.1111","volume":"37","author":[{"given":"B. S.","family":"Roman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Espuelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gamazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Irache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,23]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1084\/jem.178.6.2123","article-title":"Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals","volume":"178","author":"Secrist H","year":"1993","journal-title":"J Exp Med"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90299-4"},{"key":"e_1_2_6_4_2","first-page":"558","article-title":"Allergen immunotherapy","volume":"102","author":"Bousquet J","year":"1998","journal-title":"therapeutic vaccines for allergic diseases. A WHO position paper"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1980.tb04953.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2000.00501.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.1927.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.casemgr.2004.06.002"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(03)00194-9"},{"key":"e_1_2_6_10_2","first-page":"1231","article-title":"Drug delivery to tumours","volume":"57","author":"Reddy LH.","year":"2005","journal-title":"recent strategies"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.01884.x"},{"key":"e_1_2_6_12_2","first-page":"395","article-title":"Encapsulation of Ole e 1 in biodegradable microparticles induces Th1 response in mice","volume":"92","author":"Batanero E","year":"2003","journal-title":"a potential vaccine for allergy"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0142-9612(96)00049-X"},{"key":"e_1_2_6_14_2","first-page":"457","article-title":"Protein release from poly(epsilon\u2010caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques","volume":"8","author":"Jameela SR","year":"1997","journal-title":"a comparative study"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00177-3"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(02)00371-1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/02652040500435253"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2007.00901.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00789a030"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(80)90470-4"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/iai.57.5.1419-1426.1989","article-title":"Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis","volume":"57","author":"Gamazo C","year":"1989","journal-title":"Infect Immun"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/12.12.1733"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370390241786"},{"key":"e_1_2_6_24_2","first-page":"149","article-title":"Variations in antigen\u2010specific histamine release related with immunotherapeutic treatment","volume":"17","author":"Castillo JG","year":"1989","journal-title":"Allergol Immunopathol (Madrid)"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2003.10.009"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70492-6"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1987.tb02039.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)99876-J"},{"key":"e_1_2_6_29_2","first-page":"661","article-title":"Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide\u2010co\u2010glycolide) microparticles","volume":"81","author":"Maloy KJ","year":"1994","journal-title":"Immunology"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/7385"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00109-X"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.2003.01155.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018987404751"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1986.tb00336.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.01153.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.4049\/jimmunol.160.12.6137","article-title":"Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE\u2013allergen interaction and allergen\u2010induced basophil degranulation","volume":"160","author":"Vrtala S","year":"1998","journal-title":"J Immunol"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2007.02654.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2007.02654.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:48:58Z","timestamp":1697240938000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2007.02654.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,23]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1111\/j.1365-2222.2007.02654.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2007.02654.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,23]]}}}